Literature DB >> 15349693

[Hereditary tumor syndromes. Cutaneous manifestations and molecular pathogenesis of Gorlin and Cowden syndromes].

J Reifenberger1.   

Abstract

Several hereditary tumor syndromes are associated with characteristic skin lesions which may facilitate an early diagnosis. We summarize clinical features and recent progress in understanding the etiology and pathogenesis of two selected tumor syndromes, namely nevoid basal cell carcinoma syndrome (Gorlin syndrome) and Cowden syndrome. Both are autosomal dominantly inherited disorders. Nevoid basal cell carcinoma syndrome is characterized by the early onset of multiple basal cell carcinomas as as well as developmental defects and a predisposition for other benign and malignant tumors. The syndrome is caused by germline mutations in the PTCH tumor suppressor gene. Cowden syndrome is associated with pathognomonic mucocutaneous lesions, such as facial trichilemmomas, acral keratoses, and mucocutaneous papillomatosis. In addition, Cowden patients are predisposed to carcinomas of the thyroid, breast and endometrium. Cowden syndrome is caused by germline mutations in the PTEN tumor suppressor gene. Identification of the genes causing hereditary tumor syndromes as well as generation of genetically engineered mouse models have greatly advanced our understanding of the molecular pathogenesis of these diseases. Furthermore, novel pathogenesis-based pharmacological strategies are being developed that promise to improve prevention and therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15349693     DOI: 10.1007/s00105-004-0800-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  33 in total

1.  Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.

Authors:  Juliet A Williams; Oivin M Guicherit; Beatrice I Zaharian; Yin Xu; Ling Chai; Hynek Wichterle; Charlene Kon; Christine Gatchalian; Jeffery A Porter; Lee L Rubin; Frank Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

Review 2.  Hedgehogs tryst with the cell cycle.

Authors:  Sudipto Roy; Philip W Ingham
Journal:  J Cell Sci       Date:  2002-12-01       Impact factor: 5.285

Review 3.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 4.  The promise of retinoids to fight against cancer.

Authors:  L Altucci; H Gronemeyer
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

Review 5.  Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation.

Authors:  L G Biesecker; R Happle; J B Mulliken; R Weksberg; J M Graham; D L Viljoen; M M Cohen
Journal:  Am J Med Genet       Date:  1999-06-11

Review 6.  Protean PTEN: form and function.

Authors:  Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

Review 7.  RecQ helicases: caretakers of the genome.

Authors:  Ian D Hickson
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

8.  Ultraviolet irradiation represses PATCHED gene transcription in human epidermal keratinocytes through an activator protein-1-dependent process.

Authors:  Florence Brellier; Claire Marionnet; Odile Chevallier-Lagente; Rune Toftgard; Alain Mauviel; Alain Sarasin; Thierry Magnaldo
Journal:  Cancer Res       Date:  2004-04-15       Impact factor: 12.701

9.  Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome.

Authors:  D Kopera; L Cerroni; R Fink-Puches; H Kerl
Journal:  J Am Acad Dermatol       Date:  1996-05       Impact factor: 11.527

10.  Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten.

Authors:  Stéphanie A Backman; Danny Ghazarian; Kelvin So; Otto Sanchez; Kay-Uwe Wagner; Lothar Hennighausen; Akira Suzuki; Ming-Sound Tsao; William B Chapman; Vuk Stambolic; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-27       Impact factor: 11.205

View more
  5 in total

1.  [Photodynamic therapy for a nevoid basal cell carcinoma syndrome].

Authors:  S Hanneken; A A Sterzinger; K W Schulte; J Reifenberger
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

2.  [Meeting of the Department of Dermatology, University of Aachen].

Authors:  M Megahed; C Blazek
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

3.  [Skin tumors as marker lesions for tumor syndromes].

Authors:  T Mentzel; H Kutzner; L Requena; A Hartmann
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 4.  [Basal cell carcinoma and rare form variants].

Authors:  J Liersch; J Schaller
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 5.  [Relevance of cell culture models in cutaneous tumour biology. Part I: tumour cell lines].

Authors:  J Hatina; T Ruzicka
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.